c-Myc antisense limits rat liver regeneration and indicates role for c- Myc in regulating cytochrome P-450 3A activity

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 3, 2000, Pages 921-928

  Arora, Vikram ^a   Knapp, Derek C ^a   Smith, Barbara L ^b   Statdfield, Mary L ^a   Stein, David A ^a   Reddy, Muralimohan T ^a   Weller, Dwight D ^a   Iversen, Patrick L ^a  

^a AVI BIOPHARMA INC   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOCHROME P450 3A; OLIGOMER; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA CONTENT; ENZYME ACTIVITY; LIVER REGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEQUENCE ANALYSIS;

ANIMALS; ANTISENSE ELEMENTS (GENETICS); CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; G2 PHASE; GENES, MYC; HEPATECTOMY; LIVER; LIVER REGENERATION; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, SPRAGUE-DAWLEY; STEROID HYDROXYLASES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034008290     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Arora V and Iversen PL (2000) Antisense oligonucleotides targeted to the p53 gene modulate liver regeneration in vivo. Drug Metab Dispos 28:131-138.
2. Arora V, Iversen PL and Ebadi M (1998) Manipulation of metallothionein expression in the regenerating rat liver using antisense oligonucleotides. Biochem Biophys Res Commun 246:711-718.
3. Assy N, Gong Y, Zhang M, Pettigrew NM, Pashniak D and Minuk GY (1998) Use of proliferating cell nuclear antigen as a marker of liver regeneration after partial hepatectomy in rats. J Lab Clin Med 131:251-256.
4. Burgess TL, Fisher EF, Ross SL, Bready JV, Qian YX, Bayewitch LA, Cohen AM, Herrera CJ, Hu SS and Kramer TB (1995) The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a non-antisense mechanism. Proc Natl Acad Sci USA 92:4051-4055.
5. Crouch R and Dirksen M (1982) Ribonuclease H, in Nucleases (Linn S and Roberts R eds) pp 211-241, Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
6. El-Deiry WS (1998) p21/p53, cellular growth control and genomic integrity. Curr Top Microbiol Immunol 227:121-137.
7. Fausto N and Webber EM (1994) Liver regeneration, in The Liver: Biology and Pathobiology (Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter DA and Shafritz DA eds) pp 1059-1084, Raven Press, New York.
8. Foley J, Ton T, Maronpot R, Butterworth B and Goldsworthy TL (1993) Comparison of proliferating cell nuclear antigen to tritiated thymidine as a marker of proliferting hepatocytes in rats. Environ Health Perspect 101 (Suppl 5):199-206.
9. Fraker PJ, King LE, Lill-Elghanian D and Telford WG (1995) Quantification of apoptotic events in pure and heterogenous populations of cells using the flow cytometer. Methods Cell Biol 46:57-76.
10. Giles RV, Spiller DG, Clark RE and Tidd DM (1999) Antisense morpholino oligonucleotide analog induces missplicing of c-myc mRNA. Antisense Nucleic Acid Drug Dev 9:213-220.
11. Giles RV, Spiller DG, Grzybowski J, Clark RE, Nicklin P and Tidd DM (1998) Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells. Nucleic Acids Res 26:1567-1575.
12. Gonzalez F (1989) The molecular biology cytochrome P450s. Pharmacol Rev 40:243-287.
13. Higgins GM and Anderson RM (1931) Restoration of liver following partial surgical removal. Arch Pathol 12:186.
14. Hoffman B, Liebermann DA, Selvakumaran M and Nguyen HQ (1996) Role of c-myc in myeloid differentiation, growth arrest and apoptosis. Curr Top Microbiol Immunol 211:17-27.
15. Hudziak RM, Barofsky EB, Barofsky DF, Weller DL, Huang SB and Weller DD (1996) Resistance of morpholino phosphorodiamidate oligomers to enzymatic degradation. Nucleic Acid Drug Dev 6:267-272.
16. Hudziak RM, Summerton J, Weller DD and Iversen PL (2000) Antiproliferative effects of steric blocking phosphorodiamidate morpholine antisense agents directed against c-myc. Nucleic Acid Drug Dev, in press.
17. Huss JM and Kasper CB (1998) Nuclear receptor involvement in the regulation of rat cytochrome P450 3A23 expression. J Biol Chem 273:16155-16162.
18. Kay MA and Fausto N (1997) Liver regeneration: Prospects for therapy based on new technologies. Mol Med Today 3:108-115.
19. Kirch HE, Flaswinkel S, Rumpf H, Brockmann D and Esche H (1999) Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-kappaB and Myc/Max. Oncogene 18:2728-2738.
20. Ko LJ and Prives C (1996) p53: Puzzle and paradigm. Genes Dev 10:1054-1072.
21. Kren BT, Trembley JH and Steer CJ (1996) Alterations in mRNA stability during rat liver regeneration. Am J Physiol 270:G763-G777.
22. Michalopoulos GK and DeFrances MC (1997) Liver regeneration. Science (Wash DC) 276:60-66.
23. Nash T (1953) The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J 55:416-421.
24. Potter M and Marcu KB (1997) The c-myc story: Where we've been, where we seem to be going. Curr Top Microbiol Immunol 224:1-17.
25. Shimada T, Yamazaki H, Mimura M, Inui Y and Guengerich FP (1994) Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423.
26. Steer CJ (1995) Liver regeneration. FASEB J 9:1397-1400.
27. Summerton J and Weller D (1997a) Antisense properties of morpholino oligomers. Nucleosides Nucleotides 16:889-898.
28. Summerton J and Weller D (1997b) Morpholino antisense oligomers: Design, preparation, and properties. Antisense Nucleic Acid Drug Dev 7:187-195.
29. Tinel M, Elkahwaji J, Robin MA, Fardel N, Descatoire V, Haouzi D, Berson A and Pessayre D (1999) Interleukin-2 overexpresses c-myc and down-regulates cytochrome P-450 in rat hepatocytes. J Pharmacol Exp Ther 289:649-655.